Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer

BackgroundThe efficacy of adjuvant chemotherapy in patients with 8th edition stage IB (tumor size ≤4 cm) non-small cell lung cancer (NSCLC) remains unclear.MethodsWe identified 9757 eligible patients (non-chemotherapy group: n=8303; chemotherapy group: n=1454) between 2004 and 2016 from the Surveill...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yangyang Xu, Bing Wan, Suhua Zhu, Tianli Zhang, Jingyuan Xie, Hongbing Liu, Ping Zhan, Tangfeng Lv, Yong Song
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-01-01
Edice:	Frontiers in Oncology
Témata:	chemotherapy stage IB non-small cell lung cancer nomogram SEER
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2021.784289/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!